GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
With the emergence of various classes of blood glucose-lowering agents, choosing the appropriate drug for each patient is emphasized in diabetes management. Among incretin-based drugs, glucagon-like peptide 1 (GLP-1) receptor agonists are a promising therapeutic option for patients with diabetic kid...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
The Korean Society of Nephrology,
2022-03-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|